Watson Integration Of Andrx Underway With 66 Combined ANDAs Pending
This article was originally published in The Pink Sheet Daily
Executive Summary
With acquisition of Andrx finalized, Watson now has three business divisions: Brand, Generic and Anda distribution.
You may also be interested in...
Actavis Executive VP-U.S. Commercial And Administration Doug Boothe: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
Boothe talks with “The Pink Sheet” DAILY about follow-on biologics and other issues facing the generics industry, as well as how the top-five generics company is positioning itself to thrive in an evolving global environment.
Actavis Executive VP-U.S. Commercial And Administration Doug Boothe: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
Boothe talks with “The Pink Sheet” DAILY about follow-on biologics and other issues facing the generics industry, as well as how the top-five generics company is positioning itself to thrive in an evolving global environment.
Watson Snags Barr’s Bisaro For CEO Role
Exec, who has been with Barr since 1992, was key part of firm's Pliva acquisition.